Minerva Neurosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -7 | -7 | -7 |
EBITDA | -5,913 | -6,310 | -6,824 |
EBIT | -5,921 | -6,318 | -6,832 |
Net Income | -8,233 | -8,568 | -9,022 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,937 | -6,094 | -5,991 |
Cash | 30,981 | 34,918 | 40,912,575 |
Basic Shares | 7,568 | 7,568 | 6,506 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $41,175 |
Gross Profit | -30 | -8 | -101 | 41,175 |
EBITDA | -21,691 | -24,693 | -51,607 | 1,928 |
EBIT | -21,722 | -24,702 | -51,709 | 1,752 |
Net Income | -30,005 | -38,986 | -49,905 | 1,940 |
Net Change In Cash | 0 | 0 | 0 | 41,175 |
Cost of Revenue | 3,944 | |||
Free Cash Flow | -14,784 | -24,661 | -24,601 | -33,822 |
Cash | 40,912 | 36,093 | 60,755 | 25,356 |
Basic Shares | 6,506 | 5,340 | 5,340 | 5,114 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.54 |
2024-06-30 | -$1.09 |
2024-03-31 | -$1.13 |
2023-12-31 | -$1.39 |
